Posts

Tuesday Wonders

Vaccine platforms and limited global production capacity: what is to be done?

Around the IP Blogs

Patent exceptions in times of Covid-19: an Italian perspective

Reflections on IP exclusivity in the wake of the Corona virus outbreak